ABSTRACT
BACKGROUND: The long-term sequelae of coronavirus disease 2019 (COVID-19) in children remain poorly characterised. This study aimed to assess long-term outcomes in children previously hospitalised with COVID-19 and associated risk factors. METHODS: This is a prospective cohort study of children (≤18â years old) admitted to hospital with confirmed COVID-19. Children admitted between 2 April 2020 and 26 August 2020 were included. Telephone interviews used the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Health and Wellbeing Follow-up Survey for Children. Persistent symptoms (>5â months) were further categorised by system(s) involved. RESULTS: 518 out of 853 (61%) eligible children were available for the follow-up assessment and included in the study. Median (interquartile range (IQR)) age was 10.4 (3-15.2)â years and 270 (52.1%) were girls. Median (IQR) follow-up since hospital discharge was 256 (223-271)â days. At the time of the follow-up interview 126 (24.3%) participants reported persistent symptoms, among which fatigue (53, 10.7%), sleep disturbance (36, 6.9%) and sensory problems (29, 5.6%) were the most common. Multiple symptoms were experienced by 44 (8.4%) participants. Risk factors for persistent symptoms were: older age "6-11â years" (OR 2.74, 95% CI 1.37-5.75) and "12-18â years" (OR 2.68, 95% CI 1.41-5.4), and a history of allergic diseases (OR 1.67, 95% CI 1.04-2.67). CONCLUSIONS: A quarter of children experienced persistent symptoms months after hospitalisation with acute COVID-19 infection, with almost one in 10 experiencing multisystem involvement. Older age and allergic diseases were associated with higher risk of persistent symptoms at follow-up.
Subject(s)
COVID-19 , Adolescent , Aged , Child , Child, Hospitalized , Female , Follow-Up Studies , Humans , Prospective Studies , Risk Factors , SARS-CoV-2ABSTRACT
In recent years, bio-based production of free fatty acids from renewable resources has attracted attention for their potential as precursors for the production of biofuels and biochemicals. In this study, the oleaginous yeast Yarrowia lipolytica was engineered to produce free fatty acids by eliminating glycerol metabolism. Free fatty acid production was monitored under lipogenic conditions with glycerol as a limiting factor. Firstly, the strain W29 (Δgpd1), which is deficient in glycerol synthesis, was obtained. However, W29 (Δgpd1) showed decreased biomass accumulation and glucose consumption in lipogenic medium containing a limiting supply of glycerol. Analysis of substrate utilization from a mixture of glucose and glycerol by the parental strain W29 revealed that glycerol was metabolized first and glucose utilization was suppressed. Thus, the Δgpd1Δgut2 double mutant, which is deficient also in glycerol catabolism, was constructed. In this genetic background, growth was repressed by glycerol. Oleate toxicity was observed in the Δgpd1Δgut2Δpex10 triple mutant strain which is deficient additionally in peroxisome biogenesis. Consequently, two consecutive rounds of selection of spontaneous mutants were performed. A mutant released from growth repression by glycerol was able to produce 136.8 mg L-1 of free fatty acids in a test tube, whereas the wild type accumulated only 30.2 mg L-1 . Next, an isolated oleate-resistant strain produced 382.8 mg L-1 of free fatty acids. Finely, acyl-CoA carboxylase gene (ACC1) over-expression resulted to production of 1436.7 mg L-1 of free fatty acids. The addition of dodecane promoted free fatty acid secretion and enhanced the level of free fatty acids up to 2033.8 mg L-1 during test tube cultivation.
Subject(s)
Fatty Acids, Nonesterified/metabolism , Glycerol/metabolism , Metabolic Engineering/methods , Yarrowia/metabolism , Cell Proliferation/drug effects , Fatty Acids, Nonesterified/analysis , Fatty Acids, Nonesterified/toxicity , Glucose/metabolism , Glycerol/pharmacology , Metabolic Networks and Pathways/drug effects , Metabolic Networks and Pathways/genetics , Oleic Acid/metabolism , Oleic Acid/toxicity , Yarrowia/drug effects , Yarrowia/geneticsABSTRACT
The effects of coagulant (FeCl3·6H2O), various flocculants based on polyacrylamide (PAA), polyethylenoxide (PEO) and flocculated biomass as ballast agent, dosage and sedimental time on flocculation efficiency of harvesting Chlorella vulgaris GKV1 cultivated in a laboratory were investigated. The results of this work indicated that the flocculation efficiency achieved about 90% after 5 min of sedimentation when adding of coagulant and flocculant mixture (FeCl3 50 mg/l+PEO based Sibfloc-718 7.5 mg/l) or flocculant with ballast agent (Sibfloc-718 7.5 mg/l+10% flocculated biomass). PAA and PEO showed good flocculation efficiency at dosage of 0.025 and 0.015 g/l, respectively without pH adjustment. Finally, the most suitable flocculation method was discussed in this paper.
